首页 > 最新文献

医学最新文献

英文 中文
IF:
DNA prime and peptide boost immunization elicits robust neoantigen-specific CD8 + T cell responses and therapeutic protection in mouse tumor models. DNA引物和肽增强免疫在小鼠肿瘤模型中引起强大的新抗原特异性CD8 + T细胞反应和治疗保护。
IF 6.5 2区 医学 Q1 IMMUNOLOGY Pub Date : 2026-12-31 Epub Date: 2026-01-11 DOI: 10.1080/2162402X.2025.2606497
Pablo Morgado-Cáceres, Francisca Hofmann-Vega, Diego Figueroa, Juan Saavedra-Almarza, Felipe Gálvez-Cancino, Ximena Díaz, Evelyn Menares, Eduardo Roa, Sofia Hidalgo, Manuel Varas-Godoy, Vincenzo Borgna, Alvaro Lladser

Therapeutic immunization against tumor neoantigens has the potential to induce potent and highly selective CD8+ T-cell-mediated antitumor immunity. Consequently, immunization strategies that generate robust neoantigen-specific T-cell responses are needed. Here, we tested homologous and heterologous DNA- and peptide-based immunization strategies using a neoantigen model. We observed that priming with DNA followed by peptide boost immunization elicited the strongest CD8+ T-cell responses, which exhibited effector and memory precursor phenotypes and led to the formation of circulating and skin-resident memory T cells. In prophylactic settings, this immunization regimen delayed the growth of B16F10 melanoma and rejected EL4 lymphoma cells expressing a self-antigen. In a therapeutic setting, a DNA prime-peptide boost eliminated EL4 tumors expressing the neo-epitope model in most mice. Consistently, DNA prime-peptide boost targeting two bona fide neoepitopes of MC38 tumor model elicited neoepitope-specific CD8+ T-cell responses and a marked therapeutic effect, which may be enhanced by combining with anti-PD-1 antibody. These results highlight the potential of DNA prime-peptide boost as a promising strategy for therapeutic neoantigen immunization that elicits strong CD8+ T-cell responses and potent antitumor effects.

针对肿瘤新抗原的治疗性免疫具有诱导强效和高选择性CD8+ t细胞介导的抗肿瘤免疫的潜力。因此,需要产生强大的新抗原特异性t细胞反应的免疫策略。在这里,我们使用新抗原模型测试了基于同源和异种DNA和肽的免疫策略。我们观察到,DNA启动后的肽增强免疫引发了最强的CD8+ T细胞反应,其表现出效应和记忆前体表型,并导致循环和皮肤驻留记忆T细胞的形成。在预防性的情况下,这种免疫方案延缓了B16F10黑色素瘤的生长,并排斥了表达自身抗原的EL4淋巴瘤细胞。在治疗环境中,DNA引物肽增强消除了大多数小鼠表达新表位模型的EL4肿瘤。同样,针对MC38肿瘤模型的两个真正的新表位的DNA引物肽增强引起了新表位特异性CD8+ t细胞的反应和显著的治疗效果,可能与抗pd -1抗体联合使用会增强这种效果。这些结果突出了DNA启动肽增强作为治疗性新抗原免疫的一种有希望的策略的潜力,这种策略可以引起强烈的CD8+ t细胞反应和有效的抗肿瘤作用。
{"title":"DNA prime and peptide boost immunization elicits robust neoantigen-specific CD8 <sup>+</sup> T cell responses and therapeutic protection in mouse tumor models.","authors":"Pablo Morgado-Cáceres, Francisca Hofmann-Vega, Diego Figueroa, Juan Saavedra-Almarza, Felipe Gálvez-Cancino, Ximena Díaz, Evelyn Menares, Eduardo Roa, Sofia Hidalgo, Manuel Varas-Godoy, Vincenzo Borgna, Alvaro Lladser","doi":"10.1080/2162402X.2025.2606497","DOIUrl":"10.1080/2162402X.2025.2606497","url":null,"abstract":"<p><p>Therapeutic immunization against tumor neoantigens has the potential to induce potent and highly selective CD8<sup>+</sup> T-cell-mediated antitumor immunity. Consequently, immunization strategies that generate robust neoantigen-specific T-cell responses are needed. Here, we tested homologous and heterologous DNA- and peptide-based immunization strategies using a neoantigen model. We observed that priming with DNA followed by peptide boost immunization elicited the strongest CD8<sup>+</sup> T-cell responses, which exhibited effector and memory precursor phenotypes and led to the formation of circulating and skin-resident memory T cells. In prophylactic settings, this immunization regimen delayed the growth of B16F10 melanoma and rejected EL4 lymphoma cells expressing a self-antigen. In a therapeutic setting, a DNA prime-peptide boost eliminated EL4 tumors expressing the neo-epitope model in most mice. Consistently, DNA prime-peptide boost targeting two bona fide neoepitopes of MC38 tumor model elicited neoepitope-specific CD8<sup>+</sup> T-cell responses and a marked therapeutic effect, which may be enhanced by combining with anti-PD-1 antibody. These results highlight the potential of DNA prime-peptide boost as a promising strategy for therapeutic neoantigen immunization that elicits strong CD8<sup>+</sup> T-cell responses and potent antitumor effects.</p>","PeriodicalId":48714,"journal":{"name":"Oncoimmunology","volume":"15 1","pages":"2606497"},"PeriodicalIF":6.5,"publicationDate":"2026-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12802984/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145953143","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Methodological insights regarding the prognostic value of lncRNA PGM5P4-AS1 in breast cancer. lncRNA PGM5P4-AS1在乳腺癌预后价值的方法学见解。
IF 4.6 4区 医学 Q2 ONCOLOGY Pub Date : 2026-12-31 Epub Date: 2026-01-13 DOI: 10.1080/15384047.2026.2614802
Rashad Ismayilov, Arzu Oguz
{"title":"Methodological insights regarding the prognostic value of lncRNA PGM5P4-AS1 in breast cancer.","authors":"Rashad Ismayilov, Arzu Oguz","doi":"10.1080/15384047.2026.2614802","DOIUrl":"10.1080/15384047.2026.2614802","url":null,"abstract":"","PeriodicalId":9536,"journal":{"name":"Cancer Biology & Therapy","volume":"27 1","pages":"2614802"},"PeriodicalIF":4.6,"publicationDate":"2026-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12802980/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145958895","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epidemiology of bipolar disorder with concomitant pregnancy-induced hypertension and associated pharmacotherapies in the United States, Canada and Saudi Arabia over a five-year period (2019-2023). 美国、加拿大和沙特阿拉伯5年期间(2019-2023年)双相情感障碍合并妊娠高血压的流行病学及相关药物治疗
IF 2 3区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2026-12-31 Epub Date: 2026-01-18 DOI: 10.1080/0167482X.2025.2609622
Kelly Mover, Nicole Shirvani, Walter Wills, Suzanne Lababidi, Terrika Jones, Bryna Peplinski

Background: Rates of hypertensive disorders affecting pregnancy are increasing, and bipolar disorder is more common in pregnancy than previously thought.

Objective: The authors investigated differences in the incidence of hypertensive disorders of pregnancy between those with and without bipolar disorder (BPD) and between those receiving and not receiving pharmacotherapy for BPD. Differences in the incidence of hypertensive disorders of pregnancy in those with BPD between those on prophylactic aspirin (ASA) and not, were also examined.

Methods: EPIC COSMOS was used to examine records from 2019 to 2023.

Results: The authors found a meaningful difference in proportions between those with and without BPD when observing development of hypertensive disorders of pregnancy across years. Slightly increased odds of hypertensive disorders were found among those reporting BPD pharmacotherapy compared to those not. Slightly increased odds of hypertensive disorders occurred in those with BPD reporting ASA.

Conclusions: The increased odds among those reporting BPD pharmacotherapy could be due to sequelae of disease, medication used, or comorbidities. These findings further corroborate prior evidence of the increasing prevalence of both maternal health complications and mental health disorders int eh United States.

背景:高血压疾病影响妊娠的比率正在增加,双相情感障碍在妊娠期比以前认为的更常见。目的:研究双相情感障碍(BPD)患者和非双相情感障碍(BPD)患者以及接受和未接受BPD药物治疗的妊娠期高血压疾病发病率的差异。在BPD患者中,预防性服用阿司匹林(ASA)和未服用阿司匹林的妊娠期高血压疾病发生率的差异也进行了研究。方法:使用EPIC COSMOS对2019 - 2023年的病历进行检查。结果:作者发现,在观察妊娠期高血压疾病的发展时,有BPD和无BPD的比例有显著差异。与未接受BPD药物治疗的患者相比,接受BPD药物治疗的患者患高血压疾病的几率略有增加。报告ASA的BPD患者发生高血压疾病的几率略有增加。结论:在报告BPD药物治疗的患者中,增加的几率可能是由于疾病的后遗症、药物使用或合并症。这些发现进一步证实了先前的证据,即美国孕产妇健康并发症和精神健康障碍的患病率不断上升。
{"title":"Epidemiology of bipolar disorder with concomitant pregnancy-induced hypertension and associated pharmacotherapies in the United States, Canada and Saudi Arabia over a five-year period (2019-2023).","authors":"Kelly Mover, Nicole Shirvani, Walter Wills, Suzanne Lababidi, Terrika Jones, Bryna Peplinski","doi":"10.1080/0167482X.2025.2609622","DOIUrl":"https://doi.org/10.1080/0167482X.2025.2609622","url":null,"abstract":"<p><strong>Background: </strong>Rates of hypertensive disorders affecting pregnancy are increasing, and bipolar disorder is more common in pregnancy than previously thought.</p><p><strong>Objective: </strong>The authors investigated differences in the incidence of hypertensive disorders of pregnancy between those with and without bipolar disorder (BPD) and between those receiving and not receiving pharmacotherapy for BPD. Differences in the incidence of hypertensive disorders of pregnancy in those with BPD between those on prophylactic aspirin (ASA) and not, were also examined.</p><p><strong>Methods: </strong>EPIC COSMOS was used to examine records from 2019 to 2023.</p><p><strong>Results: </strong>The authors found a meaningful difference in proportions between those with and without BPD when observing development of hypertensive disorders of pregnancy across years. Slightly increased odds of hypertensive disorders were found among those reporting BPD pharmacotherapy compared to those not. Slightly increased odds of hypertensive disorders occurred in those with BPD reporting ASA.</p><p><strong>Conclusions: </strong>The increased odds among those reporting BPD pharmacotherapy could be due to sequelae of disease, medication used, or comorbidities. These findings further corroborate prior evidence of the increasing prevalence of both maternal health complications and mental health disorders int eh United States.</p>","PeriodicalId":50072,"journal":{"name":"Journal of Psychosomatic Obstetrics & Gynecology","volume":"47 1","pages":"2609622"},"PeriodicalIF":2.0,"publicationDate":"2026-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145999612","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gut microbiota and hypertension: role of exercise training. 肠道微生物群与高血压:运动训练的作用。
IF 3.5 4区 医学 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-12-31 Epub Date: 2025-12-27 DOI: 10.1080/10641963.2025.2608905
Meng Zhao, Qi Liu, Na-Jie Shi, Ying Li, Hong-Bao Li

Regular exercise training can significantly improve the gut environment and influence the metabolic activity of the gut microbiota. These changes promote the production of beneficial metabolites, which may modulate blood pressure regulation through multiple mechanisms. The beneficial microbial species including Faecalibacterium prausnitzii, Bifidobacterium spp., Lactobacillus spp., Roseburia spp.,and Bacteroides spp. These beneficial microbes produce various metabolites during metabolism, including short-chain fatty acids, vitamins, lactic acid, bileacids, and gamma-aminobutyric acid. These metabolites are not only essential for maintaining gut health but also positively influence hypertension by modulating the nervous system, immune system, and improving metabolic function. This review aims to elucidate the complex interactions among exercise training, gut microbiota, and hypertension.

有规律的运动训练可以显著改善肠道环境,影响肠道菌群的代谢活性。这些变化促进有益代谢物的产生,这可能通过多种机制调节血压调节。有益微生物种类包括prausnitzii Faecalibacterium, Bifidobacterium spp, Lactobacillus spp, Roseburia spp, Bacteroides spp.这些有益微生物在代谢过程中产生多种代谢物,包括短链脂肪酸,维生素,乳酸,胆汁酸,γ -氨基丁酸。这些代谢物不仅对维持肠道健康至关重要,而且还通过调节神经系统、免疫系统和改善代谢功能对高血压产生积极影响。本文旨在阐明运动训练、肠道菌群和高血压之间复杂的相互作用。
{"title":"Gut microbiota and hypertension: role of exercise training.","authors":"Meng Zhao, Qi Liu, Na-Jie Shi, Ying Li, Hong-Bao Li","doi":"10.1080/10641963.2025.2608905","DOIUrl":"https://doi.org/10.1080/10641963.2025.2608905","url":null,"abstract":"<p><p>Regular exercise training can significantly improve the gut environment and influence the metabolic activity of the gut microbiota. These changes promote the production of beneficial metabolites, which may modulate blood pressure regulation through multiple mechanisms. The beneficial microbial species including <i>Faecalibacterium prausnitzii</i>, <i>Bifidobacterium</i> spp., <i>Lactobacillus</i> spp., <i>Roseburia</i> spp.,and <i>Bacteroides</i> spp. These beneficial microbes produce various metabolites during metabolism, including short-chain fatty acids, vitamins, lactic acid, bileacids, and gamma-aminobutyric acid. These metabolites are not only essential for maintaining gut health but also positively influence hypertension by modulating the nervous system, immune system, and improving metabolic function. This review aims to elucidate the complex interactions among exercise training, gut microbiota, and hypertension.</p>","PeriodicalId":10333,"journal":{"name":"Clinical and Experimental Hypertension","volume":"48 1","pages":"2608905"},"PeriodicalIF":3.5,"publicationDate":"2026-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145846328","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vaccination status of children with special health-care needs visiting a vaccination consultation clinic of a pediatric hospital in Wuxi, China, from 2020 to 2023: A cross-sectional study. 无锡市某儿科医院2020 - 2023年特殊卫生保健需求儿童疫苗接种情况的横断面研究
IF 3.5 4区 医学 Q2 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Pub Date : 2026-12-31 Epub Date: 2026-01-21 DOI: 10.1080/21645515.2026.2613562
Lingling Wang, Xiaojuan Zhang, Xuwen Wang, Hongxia Xiang, Yuan Shen, Shixin Xiu

There has been a considerable controversy about vaccination practices of children with special health-care needs (CSHCNs) in China. We aim to describe current vaccination recommendations, immunization status, and vaccination safety of CSHCNs in Wuxi. We conducted a cross-sectional study of CSHCNs aged <18 y visiting the vaccination consultation clinic (VCC) at Wuxi Children's Hospital in 2020-2023. Demographic information was collected from Electronic Medical Records, vaccination data was obtained from Vaccination Integrated Service Management Information System of Jiangsu Province, China. Safety monitoring data was acquired from China National Adverse Events Following Immunization Information System (CNAEFIS). Descriptive data were presented as percentages, and Poisson test was used to compare the cumulative incidence of AEFIs between groups. Four thousand one hundred and twenty-two participants were included and the majority (73.0%) were under 12 months. The top three diseases consulted were those relating to the certain conditions originating in the perinatal period, developmental anomalies, and diseases of the blood or blood-forming organs. Only 6.1% had previously received all age-eligible vaccine doses before seeking evaluation. According to the vaccination guidance issued by the VCC, 59.9% were recommended to continue vaccine normally, partial vaccination was recommended for 37.2%, and 4.1% were advised to delay. A total of 3927 CSHCNs received 62,744 vaccine doses after consultation. None had serious adverse events and the cumulative incidence of AEFIs was higher than the general population of children. Specialist consultation is helpful to improve the vaccine uptake. Further research on strategies to improve the vaccination coverage of CSHCNs is warranted.

在中国,有特殊卫生保健需要的儿童的疫苗接种实践存在相当大的争议。我们的目的是描述无锡市目前的疫苗接种建议、免疫状况和疫苗接种安全性。我们对年龄较大的CSHCNs进行了横断面研究
{"title":"Vaccination status of children with special health-care needs visiting a vaccination consultation clinic of a pediatric hospital in Wuxi, China, from 2020 to 2023: A cross-sectional study.","authors":"Lingling Wang, Xiaojuan Zhang, Xuwen Wang, Hongxia Xiang, Yuan Shen, Shixin Xiu","doi":"10.1080/21645515.2026.2613562","DOIUrl":"10.1080/21645515.2026.2613562","url":null,"abstract":"<p><p>There has been a considerable controversy about vaccination practices of children with special health-care needs (CSHCNs) in China. We aim to describe current vaccination recommendations, immunization status, and vaccination safety of CSHCNs in Wuxi. We conducted a cross-sectional study of CSHCNs aged <18 y visiting the vaccination consultation clinic (VCC) at Wuxi Children's Hospital in 2020-2023. Demographic information was collected from Electronic Medical Records, vaccination data was obtained from Vaccination Integrated Service Management Information System of Jiangsu Province, China. Safety monitoring data was acquired from China National Adverse Events Following Immunization Information System (CNAEFIS). Descriptive data were presented as percentages, and Poisson test was used to compare the cumulative incidence of AEFIs between groups. Four thousand one hundred and twenty-two participants were included and the majority (73.0%) were under 12 months. The top three diseases consulted were those relating to the certain conditions originating in the perinatal period, developmental anomalies, and diseases of the blood or blood-forming organs. Only 6.1% had previously received all age-eligible vaccine doses before seeking evaluation. According to the vaccination guidance issued by the VCC, 59.9% were recommended to continue vaccine normally, partial vaccination was recommended for 37.2%, and 4.1% were advised to delay. A total of 3927 CSHCNs received 62,744 vaccine doses after consultation. None had serious adverse events and the cumulative incidence of AEFIs was higher than the general population of children. Specialist consultation is helpful to improve the vaccine uptake. Further research on strategies to improve the vaccination coverage of CSHCNs is warranted.</p>","PeriodicalId":49067,"journal":{"name":"Human Vaccines & Immunotherapeutics","volume":"22 1","pages":"2613562"},"PeriodicalIF":3.5,"publicationDate":"2026-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12826754/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146020388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute phenylcapsaicin supplementation improves CrossFit® performance: a randomized, triple-blind, placebo-controlled crossover trial. 急性苯辣椒素补充提高CrossFit®性能:一项随机、三盲、安慰剂对照交叉试验。
IF 3.9 2区 医学 Q1 NUTRITION & DIETETICS Pub Date : 2026-12-31 Epub Date: 2026-01-14 DOI: 10.1080/15502783.2026.2615274
Alejandro R Triviño, Carlos Díaz-Romero, Juan J Martin-Olmedo, Pablo Jimenez-Martinez, Carlos Alix-Fages, Magdalena Cwiklinska, Daniela Pérez, David Funes Pol, Lucas Jurado-Fasoli

Background: Phenylcapsaicin (PC) may enhance high-intensity exercise performance by reducing perceived exertion, increasing mechanical output, and limiting muscle damage, making it potentially beneficial for CrossFit® (CF) athletes.

Objective: To examine the acute effects of PC supplementation on performance, recovery, and metabolic responses during a CF session.

Methods: This study had a randomized, triple-blind, placebo-controlled crossover design. Fifty CF-trained athletes (50% women) ingested either 2.5 mg of PC or a placebo (PLA) 45 minutes before a standardized CF session, including a warm-up, weightlifting block, and WOD. Delayed-onset muscle soreness (DOMS) was assessed 24- and 48-hours post-session. Countermovement jump (CMJ) was evaluated pre- and post-session, while a deep squat at 70% 1RM was performed post-session. Throughout the session, heart rate, capillary lactate, rating of perceived exertion (RPE), and perceived recovery status (PRS) were monitored.

Results: Compared to PLA, PC improved squat performance at 70% 1RM in both load and repetitions (P ≤ 0.035), attenuated the decline in CMJ (P < 0.001), and maintained weightlifting performance over time (P interaction = 0.011), with significantly higher load in round 9 (P = 0.030). No differences were observed during the WOD (P interaction ≥ 0.826). DOMS was significantly lower in the PC group at both 24 h and 48 h (P = 0.030), while no group differences were found for lactate, RPE, PRS, or heart rate (P interaction ≥ 0.340). Analysis stratified by sex showed that PC reduced CMJ loss in men (P = 0.043) and increased squat load in women (P = 0.021).

Conclusion: In conclusion, acute PC supplementation enhances performance and recovery in CF athletes.

背景:苯辣椒素(PC)可以通过减少感知劳累、增加机械输出和限制肌肉损伤来增强高强度运动表现,使其对CrossFit®(CF)运动员有潜在的益处。目的:研究在CF期间补充PC对运动表现、恢复和代谢反应的急性影响。方法:本研究采用随机、三盲、安慰剂对照交叉设计。50名接受过CF训练的运动员(50%为女性)在进行标准化的CF训练前45分钟摄入2.5毫克PC或安慰剂(PLA),包括热身、举重和WOD。延迟性肌肉酸痛(DOMS)在治疗后24小时和48小时进行评估。在训练前和训练后评估反动作跳跃(CMJ),而在训练后进行70% 1RM的深蹲。在整个过程中,监测心率、毛细血管乳酸、感知运动等级(RPE)和感知恢复状态(PRS)。结果:与PLA相比,PC在负荷和重复训练中均提高了70% 1RM的深蹲表现(P≤0.035),减弱了CMJ的下降(P交互作用= 0.011),第9轮负荷显著提高(P = 0.030)。WOD期间无差异(P互作≥0.826)。在24 h和48 h, PC组的DOMS显著降低(P = 0.030),而乳酸、RPE、PRS或心率没有组间差异(P交互作用≥0.340)。按性别分层分析显示,PC减少了男性CMJ损失(P = 0.043),增加了女性深蹲负荷(P = 0.021)。结论:急性补充PC可提高CF运动员的运动成绩和恢复能力。
{"title":"Acute phenylcapsaicin supplementation improves CrossFit® performance: a randomized, triple-blind, placebo-controlled crossover trial.","authors":"Alejandro R Triviño, Carlos Díaz-Romero, Juan J Martin-Olmedo, Pablo Jimenez-Martinez, Carlos Alix-Fages, Magdalena Cwiklinska, Daniela Pérez, David Funes Pol, Lucas Jurado-Fasoli","doi":"10.1080/15502783.2026.2615274","DOIUrl":"10.1080/15502783.2026.2615274","url":null,"abstract":"<p><strong>Background: </strong>Phenylcapsaicin (PC) may enhance high-intensity exercise performance by reducing perceived exertion, increasing mechanical output, and limiting muscle damage, making it potentially beneficial for CrossFit<sup>®</sup> (CF) athletes.</p><p><strong>Objective: </strong>To examine the acute effects of PC supplementation on performance, recovery, and metabolic responses during a CF session.</p><p><strong>Methods: </strong>This study had a randomized, triple-blind, placebo-controlled crossover design. Fifty CF-trained athletes (50% women) ingested either 2.5 mg of PC or a placebo (PLA) 45 minutes before a standardized CF session, including a warm-up, weightlifting block, and WOD. Delayed-onset muscle soreness (DOMS) was assessed 24- and 48-hours post-session. Countermovement jump (CMJ) was evaluated pre- and post-session, while a deep squat at 70% 1RM was performed post-session. Throughout the session, heart rate, capillary lactate, rating of perceived exertion (RPE), and perceived recovery status (PRS) were monitored.</p><p><strong>Results: </strong>Compared to PLA, PC improved squat performance at 70% 1RM in both load and repetitions (<i>P</i> ≤ 0.035), attenuated the decline in CMJ (<i>P</i> < 0.001), and maintained weightlifting performance over time (<i>P</i> interaction = 0.011), with significantly higher load in round 9 (<i>P</i> = 0.030). No differences were observed during the WOD (<i>P</i> interaction ≥ 0.826). DOMS was significantly lower in the PC group at both 24 h and 48 h (<i>P</i> = 0.030), while no group differences were found for lactate, RPE, PRS, or heart rate (<i>P</i> interaction ≥ 0.340). Analysis stratified by sex showed that PC reduced CMJ loss in men (<i>P</i> = 0.043) and increased squat load in women (<i>P</i> = 0.021).</p><p><strong>Conclusion: </strong>In conclusion, acute PC supplementation enhances performance and recovery in CF athletes.</p>","PeriodicalId":17400,"journal":{"name":"Journal of the International Society of Sports Nutrition","volume":"23 1","pages":"2615274"},"PeriodicalIF":3.9,"publicationDate":"2026-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12810409/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145971150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Balancing hope and uncertainty: family perspectives on lung transplantation in cystic fibrosis - a qualitative study. 平衡希望与不确定性:囊性纤维化患者肺移植的家庭观点-一项定性研究。
IF 2.3 4区 医学 Q2 NURSING Pub Date : 2026-12-31 Epub Date: 2026-01-24 DOI: 10.1080/17482631.2026.2620417
Ulrika Skogeland, Isabelle de Monestrol, Tove Godskesen

Purpose: Cystic fibrosis (CF) is a genetic disease primarily affecting the lungs and digestive system. Individuals with advanced CF lung disease may require transplantation to survive. Family members often take on significant caregiving roles, facing both emotional and practical challenges throughout the transplantation process. This study explores the experiences of such family members to inform and improve supportive care practices.

Method: Employing a naturalistic, exploratory design, this qualitative study used purposive sampling to recruit 19 family members of lung transplant recipients with CF. Data were collected through semi-structured interviews and analysed using reflexive thematic analysis.

Results: The analysis identified three main themes and eight subthemes: (I) balancing hope and despair on the waiting list, (II) navigating challenges and finding relief after the transplantation, and (III) unmet support and informational needs before and after transplantation.

Conclusion: This study highlights the emotional burden and caregiving responsibilities shouldered by family members of individuals with CF who have undergone lung transplantation. The findings emphasise the importance of person- and family-centred interventions, including support for palliative care discussions. A more structured and inclusive framework is essential to address the often-overlooked needs of families throughout the transplantation process.

目的:囊性纤维化(CF)是一种主要影响肺部和消化系统的遗传性疾病。晚期CF肺病患者可能需要移植才能生存。家庭成员往往承担重要的照顾角色,在整个移植过程中面临情感和实际的挑战。本研究探讨这些家庭成员的经验,以告知和改善支持性护理实践。方法:采用自然主义的探索性设计,本定性研究采用目的性抽样方法,招募19例肺移植术后CF患者的家庭成员,采用半结构化访谈法收集数据,并采用自反性主题分析法进行分析。结果:分析确定了三个主要主题和八个副主题:(I)平衡等待名单上的希望和绝望,(II)导航挑战并在移植后找到救济,(III)移植前后未满足的支持和信息需求。结论:本研究突出了CF患者肺移植后家庭成员所承担的情感负担和照顾责任。研究结果强调了以个人和家庭为中心的干预措施的重要性,包括对姑息治疗讨论的支持。一个更加结构化和包容性的框架对于解决在整个移植过程中往往被忽视的家庭需求至关重要。
{"title":"Balancing hope and uncertainty: family perspectives on lung transplantation in cystic fibrosis - a qualitative study.","authors":"Ulrika Skogeland, Isabelle de Monestrol, Tove Godskesen","doi":"10.1080/17482631.2026.2620417","DOIUrl":"10.1080/17482631.2026.2620417","url":null,"abstract":"<p><strong>Purpose: </strong>Cystic fibrosis (CF) is a genetic disease primarily affecting the lungs and digestive system. Individuals with advanced CF lung disease may require transplantation to survive. Family members often take on significant caregiving roles, facing both emotional and practical challenges throughout the transplantation process. This study explores the experiences of such family members to inform and improve supportive care practices.</p><p><strong>Method: </strong>Employing a naturalistic, exploratory design, this qualitative study used purposive sampling to recruit 19 family members of lung transplant recipients with CF. Data were collected through semi-structured interviews and analysed using reflexive thematic analysis.</p><p><strong>Results: </strong>The analysis identified three main themes and eight subthemes: (I) balancing hope and despair on the waiting list, (II) navigating challenges and finding relief after the transplantation, and (III) unmet support and informational needs before and after transplantation.</p><p><strong>Conclusion: </strong>This study highlights the emotional burden and caregiving responsibilities shouldered by family members of individuals with CF who have undergone lung transplantation. The findings emphasise the importance of person- and family-centred interventions, including support for palliative care discussions. A more structured and inclusive framework is essential to address the often-overlooked needs of families throughout the transplantation process.</p>","PeriodicalId":51468,"journal":{"name":"International Journal of Qualitative Studies on Health and Well-Being","volume":"21 1","pages":"2620417"},"PeriodicalIF":2.3,"publicationDate":"2026-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12833888/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146042144","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
'Outbreak distress': Characterising moral distress among international healthcare workers responding to mpox. “爆发痛苦”:描述应对麻疹的国际卫生保健工作者的道德痛苦。
IF 2.1 3区 医学 Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2026-12-31 Epub Date: 2026-02-02 DOI: 10.1080/17441692.2025.2607848
Rosalie Hayes, Anthony K J Smith, Sara Paparini, Vanessa Apea, Martin Holt, Chloe Orkin

In May 2022, a global outbreak of mpox (formerly known as monkeypox) was declared an international public health emergency. During this time, healthcare workers scrambled to respond to the outbreak amidst a lack of resources, knowledge gaps and pressures related to COVID-19. This period posed a risk of heightened moral distress, defined as distress arising from a situation in which a healthcare worker knows the right thing to do but is externally constrained from doing so. An international survey of healthcare workers was developed to understand their experiences of responding to mpox, including open-text questions regarding moral distress. Drawing on thematic analysis of these open text responses, this paper conceptualises the forms of distress experienced by health workers as 'outbreak distress'-an emotional and psychological response to the synergistic effects that arise from stressed systems, uncertainty and stigma that characterise many, and especially new, infectious disease outbreaks. In the context of pandemic preparedness, outbreak distress represents a novel concept for understanding additional pressures on healthcare systems in future unknown and re-emerging outbreaks.

2022年5月,全球暴发的麻疹(以前称为猴痘)被宣布为国际突发公共卫生事件。在此期间,卫生保健工作者在缺乏资源、知识差距和与COVID-19相关的压力下争先恐后地应对疫情。这一时期带来了道德困境加剧的风险,道德困境的定义是由于卫生保健工作者知道该做什么,但受到外部限制而无法这样做的情况下产生的困境。开展了一项针对卫生保健工作者的国际调查,以了解他们应对麻疹的经验,包括关于道德困境的开放式文本问题。根据对这些公开文本回应的专题分析,本文将卫生工作者所经历的痛苦形式概念化为“爆发痛苦”——对压力系统、不确定性和污名所产生的协同效应的情感和心理反应,这些是许多,特别是新的传染病爆发的特征。在大流行防范的背景下,疫情困扰代表了一个新的概念,用于理解未来未知和重新出现的疫情对卫生保健系统的额外压力。
{"title":"'Outbreak distress': Characterising moral distress among international healthcare workers responding to mpox.","authors":"Rosalie Hayes, Anthony K J Smith, Sara Paparini, Vanessa Apea, Martin Holt, Chloe Orkin","doi":"10.1080/17441692.2025.2607848","DOIUrl":"https://doi.org/10.1080/17441692.2025.2607848","url":null,"abstract":"<p><p>In May 2022, a global outbreak of mpox (formerly known as monkeypox) was declared an international public health emergency. During this time, healthcare workers scrambled to respond to the outbreak amidst a lack of resources, knowledge gaps and pressures related to COVID-19. This period posed a risk of heightened moral distress, defined as distress arising from a situation in which a healthcare worker knows the right thing to do but is externally constrained from doing so. An international survey of healthcare workers was developed to understand their experiences of responding to mpox, including open-text questions regarding moral distress. Drawing on thematic analysis of these open text responses, this paper conceptualises the forms of distress experienced by health workers as 'outbreak distress'-an emotional and psychological response to the synergistic effects that arise from stressed systems, uncertainty and stigma that characterise many, and especially new, infectious disease outbreaks. In the context of pandemic preparedness, outbreak distress represents a novel concept for understanding additional pressures on healthcare systems in future unknown and re-emerging outbreaks.</p>","PeriodicalId":12735,"journal":{"name":"Global Public Health","volume":"21 1","pages":"2607848"},"PeriodicalIF":2.1,"publicationDate":"2026-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146105148","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
QuantiFERON-TB gold plus in people living with HIV: independence from CD4+ T-cell counts in a low TB-burden setting. QuantiFERON-TB gold plus在艾滋病毒感染者中的应用:在低结核病负担环境中不依赖CD4+ t细胞计数
IF 1.8 4区 医学 Q3 INFECTIOUS DISEASES Pub Date : 2026-12-31 Epub Date: 2026-02-03 DOI: 10.1080/25787489.2026.2624947
Erika Asperges, Roberto Gulminetti, Laura Maiocchi, Stefano Novati, Layla Pagnucco, Paolo Sacchi, Valentina Zuccaro, Angelo Tavano, Francesco Siviero, Pietro Guidicini, Enrica Bono, Giuseppe Albi, Patrizia Cambieri, Bianca V Mariani, Raffaele Bruno

Background: Tuberculosis screening is recommended for people living with HIV. The QuantiFERON-TB test measures the cell-mediated response against M. Tuberculosis. The Gold-In-Tube measures the response of CD4+ T-cells, often leading to indeterminate results. The new Gold-Plus (QFT-GP) also measures CD8+ T-cells response, thus reducing uncertainties. However, studies on people living with HIV, that would benefit from a test independent from CD4+ T-cells, are scarce.

Objective: This study addresses this gap by evaluating the performance of QFT-GP specifically in a large cohort of people living with HIV in a low TB-endemic setting.

Methods: We retrospectively evaluated the frequency of indeterminate QFT-GP tests in a cohort of people living with HIV with at least one test. We collected demographic data, CD4+ and CD8+ T-cell count at nadir and at the time of testing, and history of prior TB infection or treatment. We correlated the QFT-GP results to the CD4+ T-cell count.

Results: Six hundred and ninety five patients were included (males/females 72.5/27.5%), median age was 51 ± 14 years. Only 1,2% of tests were indeterminate, and there was no association with the CD4+ or CD8+ T-cell count at the moment of the test or at the nadir.

Conclusions: QFT-GP has few indeterminate results, even in patients with a low CD4+ T-cell count.

背景:建议对艾滋病毒感染者进行结核病筛查。QuantiFERON-TB试验测量细胞介导的对结核分枝杆菌的反应。金管测量CD4+ t细胞的反应,经常导致不确定的结果。新的Gold-Plus (QFT-GP)也测量CD8+ t细胞反应,从而减少了不确定性。然而,对艾滋病毒感染者的研究很少,这种研究将受益于独立于CD4+ t细胞的测试。目的:本研究通过评估QFT-GP在低结核病流行环境中大量艾滋病毒感染者中的表现来解决这一差距。方法:我们回顾性地评估了至少进行过一次检测的HIV感染者队列中不确定QFT-GP检测的频率。我们收集了人口统计数据,CD4+和CD8+ t细胞计数在最低点和测试时,以及以前的结核病感染或治疗史。我们将QFT-GP结果与CD4+ t细胞计数相关联。结果:纳入695例患者(男/女72.5/27.5%),中位年龄51±14岁。只有1.2%的测试是不确定的,并且在测试的那一刻或最低点与CD4+或CD8+ t细胞计数没有关联。结论:即使在CD4+ t细胞计数低的患者中,QFT-GP也几乎没有不确定的结果。
{"title":"QuantiFERON-TB gold plus in people living with HIV: independence from CD4+ T-cell counts in a low TB-burden setting.","authors":"Erika Asperges, Roberto Gulminetti, Laura Maiocchi, Stefano Novati, Layla Pagnucco, Paolo Sacchi, Valentina Zuccaro, Angelo Tavano, Francesco Siviero, Pietro Guidicini, Enrica Bono, Giuseppe Albi, Patrizia Cambieri, Bianca V Mariani, Raffaele Bruno","doi":"10.1080/25787489.2026.2624947","DOIUrl":"https://doi.org/10.1080/25787489.2026.2624947","url":null,"abstract":"<p><strong>Background: </strong>Tuberculosis screening is recommended for people living with HIV. The QuantiFERON-TB test measures the cell-mediated response against <i>M. Tuberculosis</i>. The Gold-In-Tube measures the response of CD4+ T-cells, often leading to indeterminate results. The new Gold-Plus (QFT-GP) also measures CD8+ T-cells response, thus reducing uncertainties. However, studies on people living with HIV, that would benefit from a test independent from CD4+ T-cells, are scarce.</p><p><strong>Objective: </strong>This study addresses this gap by evaluating the performance of QFT-GP specifically in a large cohort of people living with HIV in a low TB-endemic setting.</p><p><strong>Methods: </strong>We retrospectively evaluated the frequency of indeterminate QFT-GP tests in a cohort of people living with HIV with at least one test. We collected demographic data, CD4+ and CD8+ T-cell count at nadir and at the time of testing, and history of prior TB infection or treatment. We correlated the QFT-GP results to the CD4+ T-cell count.</p><p><strong>Results: </strong>Six hundred and ninety five patients were included (males/females 72.5/27.5%), median age was 51 ± 14 years. Only 1,2% of tests were indeterminate, and there was no association with the CD4+ or CD8+ T-cell count at the moment of the test or at the nadir.</p><p><strong>Conclusions: </strong>QFT-GP has few indeterminate results, even in patients with a low CD4+ T-cell count.</p>","PeriodicalId":13165,"journal":{"name":"HIV Research & Clinical Practice","volume":"27 1","pages":"2624947"},"PeriodicalIF":1.8,"publicationDate":"2026-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146112962","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Confronting fear and uncertainty: adults' experiences of undergoing a food challenge test for food allergy. 面对恐惧和不确定性:成年人对食物过敏进行食物挑战测试的经历。
IF 2.3 4区 医学 Q2 NURSING Pub Date : 2026-12-31 Epub Date: 2026-02-06 DOI: 10.1080/17482631.2026.2626841
Melina Makatsori, Anne Miles

Background: Oral food challenges are indicated when food allergies cannot be confirmed by clinical history or investigations, such as blood or skin-prick tests. However, few studies have examined adults' experiences of oral food challenges.

Methods: Semi-structured, individual interviews were conducted with 18 adults who had undergone an oral food challenge at a UK hospital.

Results: Three main themes were identified using thematic analysis, describing experiences before, during, and after testing: "A limited and scared life," "facing fear and uncertainty in a safe environment," and "living with revised boundaries." Prior to the test, participants described a life characterized by fear of reactions, hypervigilance, planning and restrictive diets, limiting social participation. During testing, participants experienced an emotional rollercoaster, confronting something previously avoided, which could potentially cause a severe reaction. After testing, participants reported reduced fear and uncertainty following clarification of their allergies, leading to greater freedom, and for those who tested negative, a return to viewing food as a source of pleasure, rather than fear.

Conclusions: Oral food challenges reduce fear and uncertainty surrounding allergies, providing clarity about which foods trigger reactions. Greater availability of oral food challenges would enable adults with suspected allergies to live less restricted and more enjoyable lives.

{"title":"Confronting fear and uncertainty: adults' experiences of undergoing a food challenge test for food allergy.","authors":"Melina Makatsori, Anne Miles","doi":"10.1080/17482631.2026.2626841","DOIUrl":"https://doi.org/10.1080/17482631.2026.2626841","url":null,"abstract":"<p><strong>Background: </strong>Oral food challenges are indicated when food allergies cannot be confirmed by clinical history or investigations, such as blood or skin-prick tests. However, few studies have examined adults' experiences of oral food challenges.</p><p><strong>Methods: </strong>Semi-structured, individual interviews were conducted with 18 adults who had undergone an oral food challenge at a UK hospital.</p><p><strong>Results: </strong>Three main themes were identified using thematic analysis, describing experiences before, during, and after testing: \"A limited and scared life,\" \"facing fear and uncertainty in a safe environment,\" and \"living with revised boundaries.\" Prior to the test, participants described a life characterized by fear of reactions, hypervigilance, planning and restrictive diets, limiting social participation. During testing, participants experienced an emotional rollercoaster, confronting something previously avoided, which could potentially cause a severe reaction. After testing, participants reported reduced fear and uncertainty following clarification of their allergies, leading to greater freedom, and for those who tested negative, a return to viewing food as a source of pleasure, rather than fear.</p><p><strong>Conclusions: </strong>Oral food challenges reduce fear and uncertainty surrounding allergies, providing clarity about which foods trigger reactions. Greater availability of oral food challenges would enable adults with suspected allergies to live less restricted and more enjoyable lives.</p>","PeriodicalId":51468,"journal":{"name":"International Journal of Qualitative Studies on Health and Well-Being","volume":"21 1","pages":"2626841"},"PeriodicalIF":2.3,"publicationDate":"2026-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146133047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
全部 ACS Chem. Neurosci. ACS Infect. Dis. ACS Med. Chem. Lett. Chem. Res. Toxicol. J. Med. Chem. Mol. Pharmaceutics Toxicol. Res. Acta Physiol. ACTA PSYCHIAT SCAND Addiction Aliment. Pharmacol. Ther. Allergy AM J TRANSPLANT Ann. Clin. Transl. Neurol. Ann. Neurol. Arch. Pharm. ARTHRITIS RHEUMATOL AUTISM RES Br. J. Haematol. BRIT J SURG CA-CANCER J CLIN CANCER-AM CANCER SOC CANCER MED-US CHEM BIOL DRUG DES ChemMedChem Clin. Transl. Immunol. Clin. Pharmacol. Ther. CNS Neurosci. Ther. DIABETES OBES METAB DIGEST ENDOSC Drug Test. Anal. EUR J HEART FAIL Eur. J. Immunol. Glia Hepatology Immunol. Rev. Int. J. Cancer J. Bone Miner. Res. J CACHEXIA SARCOPENI J CHILD PSYCHOL PSYC J. Diabetes J DIABETES INVEST J INTERN MED J. Pineal Res. J INT AIDS SOC Med. Res. Rev. MOVEMENT DISORD Obesity OBES REV PEDIATR OBES Pigm. Cell Melanoma Res. STEM CELLS J. Pathol. Appetite BIOORGAN MED CHEM BIOORG MED CHEM LETT Chem. Biol. Interact. Cytokine DNA Repair Drug Discovery Today Eur. J. Med. Chem. Forensic Chem. J ACAD NUTR DIET Neurochem. Int. Pharmacol. Ther. Chemosens. Percept. J. Mol. Neurosci. J NAT MED-TOKYO J PHARM INNOV Med. Chem. Res. Neurochem. Res. ACTA OTO-LARYNGOL ACTA OTORHINOLARYNGO ACTA PAUL ENFERM 海军军医大学学报 中医药学报 ACTA ANAESTH SCAND ACTA NEUROPATHOL COM ACTA OPHTHALMOL ACTA ORTHOP ACTA DIABETOL AAPS PHARMSCITECH ACTA PARASITOL ACTA CHIR BELG Acta Neurol. Scand. Acta Pharmacol. Sin. ACTA DERM-VENEREOL ACTA CARDIOL SIN ACTA CYTOL ACTA CARDIOL ACTA CHIR ORTHOP TR ACTA HAEMATOL-BASEL ACTA OBSTET GYN SCAN ACTA CIR BRAS Acta Neuropathol. ACTA MED OKAYAMA ACTA ORTHOP BELG ACTA NEUROBIOL EXP ACTA PHARMACEUT ACTA NEUROL BELG
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1